LINK:

OBJECTIVES: Upon completion of this activity, the participant should be able to: 

(1) Identify patients with hypertrophic cardiomyopathy

(2) Discuss guideline recommended monitoring of hypertrophic cardiomyopathy patients and families

(3) Discuss the treatment of patients with symptomatic hypertrophic cardiomyopathy

FACULTY DISCLOSURE: David Rawitscher, MD has relevant financial relationship(s) with Zoll/Itimar and Bristol-Myers Squibb as a consultant.

PLANNER DISCLOSURE:  Jennifer Zimmer, MD and Jamie Davidson have no relevant financial relationships to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated.
 

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For assistance please contact Jamie Davidson at [email protected]